The steroid and xenobiotic receptor (SXR) is a broad-specificity nuclear hormone receptor that is highly expressed in the liver and intestine, where its primary function is to regulate drug and xenobiotic metabolism. SXR is expressed at lower levels in other tissues, where little is known about its physiological functions. We previously linked SXR with immunity and inflammation by showing that SXR antagonizes the activity of nuclear factor (NF)-B in vitro and in vivo. SXR 
T he steroid and xenobiotic receptor (SXR) (also known as PXR, PAR, and NR1I2) is a broad-specificity, low-affinity nuclear hormone receptor that is activated by numerous drugs, xenobiotic chemicals, and dietary compounds. Strong SXR activators include rifampicin, taxol, mifepristone, clotrimazole, phenytoin, and hyperforin (reviewed in Ref. 1) . The primary function of SXR is thought to be the transcriptional regulation of xenobiotic metabolism enzymes such as cytochrome P450 (CYP) genes, conjugating enzymes, and ABC family transporters.
We and others previously showed that SXR and the nuclear factor (NF)-B signaling pathways are mutually inhibitory in vitro and in vivo (2, 3) . NF-B is widely expressed and functions as a key regulator of the immune response and inflammation. SXR Ϫ/Ϫ mice express high levels of NF-B target genes in tissues with robust SXR expression, such as the liver and intestine, and chronic inflammation was found in knockout (KO) animals. SXR activators inhibit the expression of NF-B target genes in vitro and in vivo in an SXR-dependent fashion (2) . Inhibiting NF-B activity augmented SXR induction of its target genes, whereas NF-B activation blunted SXR signaling and decreased expression of genes encoding drug-metabolizing enzymes such as CYP4A4 (2, 3) . Considering that NF-B is intimately involved in immune function and that disruption of NF-B has been previously implicated in a wide range of biological disorders (4), we inferred that disruption of SXR and consequent chronic activation of NF-B would lead to significant in vivo consequences. Among its many known functions, NF-B regulates both the proliferation of lym-phocytes and lymphocyte apoptosis (3) . Sustained NF-B up-regulation has been previously shown to drive transformation of lymphocytes to lymphatic tumors during chronic infection; notably, gastric mucosa-associated lymphoid tissue lymphoma has been linked to persistent Helicobacter pylori infection (5) . Furthermore, chronic inflammation raises the risk of other types of cancer; for example, inflammatory bowel disease is associated with the development of colon cancer, and prostatitis is linked to the development of prostate cancer (6) . Additional data support a causal association between NF-B and oncogenesis (reviewed in Refs. 6 and 7). There is clear evidence that NF-B is involved in tumor initiation and development in tissues in which cancer-associated inflammation is often seen, such as the liver and intestine (8, 9) .
Our analysis of SXR Ϫ/Ϫ animals of increasingly advanced age revealed that, in addition to the intestinal inflammation found in young animals (2), older animals developed an influx of B-1 cells. Beginning at 6 months of age, we observed multifocal lymphomas in the intestine, spleen, and lymph nodes comprised of B-1 cells. This phenotype was observed in both sexes, although a higher penetrance was observed in females, a phenomenon consistent with other studies of sexually dimorphic immune function (10 -12 
Results

SXR
؊/؊ mice develop a lymphoproliferative syndrome that progresses with age To investigate a potential role of SXR in NF-B-mediated oncogenesis, we analyzed human cancer transcriptome profiles for SXR expression. Published studies summarized in the Oncomine database showed that SXR may be downregulated in several premalignant states and lymphatic tumors (Table 1) , including B cell malignancies such as B cell acute lymphoblastic leukemia, centroblastic lymphoma, and Burkitt's Lymphoma as well as diffuse large B cell lymphoma, mantle cell lymphoma, and CLL. To determine whether loss of SXR might be a cause rather than an effect of B lymphoid transformation, we examined lymphoid tissue in SXR Ϫ/Ϫ animals and found large lymphoid accumulations in the spleen, lymph nodes, and intestine with increasing age (Fig. 1, A and C) . This progressive evolution of lymphoproliferative lesions (Fig. 1A) was found in approximately 75% of males and 85% of females. Lymphocyte proliferation was first evident in the intestine, an area of high SXR expression in wild-type (WT) mice. Enlarged Peyer's patches and intestinal inflammation were noted at 8 wk, accompanied by a strong up-regulation of proinflammatory genes, in accord with our previous findings (2) . Splenomegaly was observed beginning at 20 wk. Intestinal tumors were evident at 20 -24 wk, and lymph node tumors developed in some animals. Apparent tumors were observed in other organs by 24 -28 wk of age. SXR Ϫ/Ϫ spleens were enlarged, ranging in weight from 0.2-1 g vs. 0.1 g in controls (Fig. 1B) and showed expansion of the white pulp with pronounced effacement of the germinal center regions (Fig. 1C) . Inguinal, axillary, brachial, and cervical lymph nodes were enlarged 5-to 15-fold compared with WT animals (Fig. 1C) . by unique surface markers, the capacity to self-replenish, and a restricted tissue distribution (13, 15, 16) . B-1 cells can be subdivided into B-1a cells, which express CD5, and B-1b cells, which do not (13) .
We next characterized the nature of cells contributing to the splenomegaly and lymphadenopathy in aged SXR Ϫ/Ϫ animals. Consistent with an inflammatory environment, we found moderate increases in neutrophils and CD8 ϩ T cells (Supplemental Fig. 1 Fig. 2A) . The proportion of B-1a cells recovered from peritoneal lavage and in the peripheral blood tripled in KO animals ( Fig.  2B) , and the total cell yield from peritoneal lavage increased in KO animals (Supplemental Fig. 2 ). These B-1 cells also expressed CD21 and CD38 (Supplemental Fig. 3 ), markers expressed on CLL/SLL cells, a disease thought to be of B-1a cell origin (17) . CD38 is used as a clinical marker for poor prognosis and the need for aggressive treatment of CLL/SLL (18) . The number of B cells expressing or light chain normally remains constant. In humans, the ratio varies from 50:50 to 65:35, whereas 90 -95% of mouse B cells express the light chain for a ratio of 20:1 (19, 20) . SXR Ϫ/Ϫ mice demonstrate an elevated to ratio (a change from 20:1 to to 100% ), suggestive of a monoclonal expansion of a B cell subpopulation (Fig. 2C ). An altered to ratio is also used as a diagnostic criterion for CLL/SLL (21, 22) . Analysis of the V H DJ H sequences of the V H DJ H -Cmu transcripts from SXR Ϫ/Ϫ splenocytes revealed that 35% of all transcripts present had identical length and alignment. DNA sequencing and bioinformatic analysis suggested that these were a clonal population (Supplemental Fig. 4 ). These results are consistent with the presence of B-1a B cell monoclonal lymphoproliferative disease in SXR Ϫ/Ϫ animals. Decreased body weight and splenomegaly are associated with lymphoproliferative syndrome and lymphoma, resulting in an increase in the spleen to body weight ratio (23, 24) . Aged female SXR Ϫ/Ϫ mice weigh less than 21 g compared with 24 g for WT animals and have a concomitant increase in the spleen to body weight ratio (Fig. 2D ).
FIG. 1. SXR Ϫ/Ϫ mice develop a lymphoproliferative syndrome that progresses with age. A, SXR
Ϫ/Ϫ animals develop severe inflammation and acute lymphoproliferations and ultimately develop lymphoma; B, spleens of aged SXR Ϫ/Ϫ animals are enlarged, ranging from 0.2-1 g (as compared with 0.1 g for strain-and age-matched control animals); C, hematoxylin-and eosinstained slides for WT and KO animals indicate inflammation, lymphoproliferation, and disruption of normal architecture in aged SXR KO animals. Original magnification for all panels, ϫ40.
SXR
؊/؊ mice demonstrate elevated Ig in
peripheral blood
Patients with CLL/SLL can present with elevated serum Ig (25, 26) . Therefore, we used serum protein electrophoresis to ascertain whether serum Ig levels were altered by loss of SXR. The mean ␥-globulin concentration (0. SXR is present in lymphatic tissues, and loss of function promotes lymphocyte proliferation SXR is highly expressed in the liver and small intestine with moderate expression in the lung, kidney, bone, and breast (1). It is controversial whether SXR is expressed or functions in other tissues. Some investigators reported expression of SXR and its target genes in peripheral blood mononuclear cells (27, 28) 3C) . Together, these data indicate that SXR is expressed in lymphatic tissues and opposes spontaneous lymphocyte survival and proliferation.
SXR regulates lymphocyte proliferation and apoptosis through NF-B signaling
We previously reported a mutually inhibitory cross talk between SXR and NF-B (2). Because NF-B affects cell division and proliferation through expression of cmyb and c-jun (32), we examined levels of these genes in control and SXR Ϫ/Ϫ spleens. As expected, quantitative real-time PCR (qRT-PCR) analysis revealed significant increases in the expression of both genes (Fig. 4, A and B) . We infer from these results that loss of SXR function leads to increased NF-B function and up-regulation of proproliferation genes. In addition to increased proliferation, we expected that changes in the levels of apoptosis could alter lymphocyte number. Accordingly, expression of the proapoptotic gene Bad was significantly decreased (Fig. 4D) . The antiapoptotic Bcl-xL was up-regulated nearly 4-fold compared with controls (Fig. 4C) . In vivo activation of SXR in WT mice by a 3-d treatment with a strong activator, pregnenolone-16-carbonitrile (PCN), led to significant downregulation of c-jun, c-myb, and Bcl-xL, further securing a role for SXR in cell proliferation and apoptosis (Fig. 4G) . PCN-treated SXR KO animals showed no change in expression of these transcripts as compared with vehicle control, as expected (Supplemental Fig. 6 ).
We next sought to confirm up-regulation of NF-B signaling in lymphatic tissues by analyzing additional NF-B target genes in spleen. TNF␣ was strongly increased (Fig.  4E) , and COX-2 was also significantly increased (Fig. 4F ). After treatment with the NF-B inhibitor caffeic acid phenethyl ester (CAPE), Bcl-xL was strongly down-regulated, 9D ). Recent work on negative regulators of B-1 cell expansion directed us toward Siglec-G, protein tyrosine phosphatase, non-receptor type 6 (PTPN6) (mouse orthologs of human Siglec-10 and Shp1, respectively), Lck, and zeta-chain-associatedprotein kinase 70 (Zap-70). KO mice for both Siglec-G (34, 35) and PTPN6 (36) exhibit an expansion of B-1a cells, suggesting that these proteins normally act as negative regulators of B-1a proliferation. qRT-PCR analysis of splenocyte mRNA expression revealed that both Siglec-G (3-fold) and PTPN6 (nearly 2-fold) were downregulated in SXR Ϫ/Ϫ animals (Fig. 5, A and B) . This implicates SXR as a factor that normally promotes expression of genes that oppose B-1a cell proliferation. The Src family kinase Lck, which is normally dephosphorylated at stimulatory site Tyr-394 and down-regulated by PTPN6 (37, 38) , is up-regulated in SXR Ϫ/Ϫ animals ( Fig. 5C ). Lck is expressed in CLL/SLL cells where it may confer self-replenishing capability (39, 40) . Lck normally phosphorylates Zap-70 (at Tyr-319) thereby activating it (41); Zap-70 mRNA is also up-regulated in SXR Ϫ/Ϫ animals (Fig. 5D ). Zap-70 expression has also been associated with advanced CLL and indicates a need for aggressive treatment (42, 43 (Fig. 5F ), confirming that Lck is active. Next, we asked whether this B-1a cell signaling pathway was directly modulated by SXR activity in WT animals. SXR, Siglec-G, PTPN6, Lck, and Zap-70 expression were measured by qRT-PCR on tissues harvested 3 d after PCN treatment (Fig. 5, G and H) . Siglec-G was up-regulated 1.5-fold in spleen and in peritoneal B-1a cells. PTPN6 was upregulated nearly 2-fold in spleen and nearly 1.5-fold in B-1a cells. Lck was down-regulated 2-fold in spleen and 1.3-fold in B-1a cells. Zap-70 was down-regulated 1.3-fold in spleen and nearly 2-fold in B-1a cells. After ligand treatment, SXR expression was also up-regulated approximately 3-fold in both tissues (Fig. 5E ). Spleens from SXR KO animals treated with PCN showed no changes in the expression of these transcripts compared with vehicle control (Supplemental Fig. 6 ). Finally, because loss of SXR led to up-regulation of positive regulators (Fig. 5, C and D) and down-regulation of negative regulators of this pathway (Fig. 5, A and B) and that loss of SXR led to increased activation of NF-B, we hypothesized that inhibition of NF-B activity would reproduce the effects of activating SXR. After a 24-h treatment with CAPE, B-1a cell checkpoints PTPN6 and Siglec-G were up-regulated nearly 2-fold in a dose-dependent manner, whereas Lck was moderately down-regulated (Supplemental Fig. 4) . Together, these results confirm the NF-B-dependent role of SXR as a negative regulator of B-1a cell proliferation. (Fig. 6C) , enlarged lymph nodes, and large numbers of B220
B-1 cell tumors from SXR
ϩ cells were found in the lymph nodes (an average of 20%), spleen (ϳ14%) unchallenged peritoneal lavage (ϳ10%), and peripheral blood (3%) (Fig. 6B) . No B-1a cells or enlarged spleens were found in animals that were sublethally irradiated but received WT B-1a cells. mice develop enlarged spleens and lymph nodes, and their pathology resembles the human disease CLL/SLL. Gene expression analysis reveals a pivotal role of SXR in expansion of the B-1a compartment as well as regulation of proliferation and apoptosis. We infer from these results that SXR regulates a crucial step in the development of B-1a B cells. B-1a B cells are generated almost entirely in the fetal liver (13, 16, 45) and not in the bone marrow as are other lymphocytes, although there may be few B-1 precursors in the bone marrow that rarely give rise to B-1a cells (15) . It is likely that SXR expression, or the expression of one or more SXR target genes, serves as a checkpoint in the development or self-renewal of B-1 B cells. SXR activity at age embryonic d 10 -11 may be particularly important, because this is when the fetal liver begins to actively produce lymphocytes (46) . B-1 cells subsequently migrate to the peritoneum where they continue to self-replenish; SXR may continue to function as a checkpoint for B-1 cell growth and proliferation throughout life. It is also notable that the liver and gut are locations of high SXR expression and activity in WT animals, suggesting that regulation of lymphocyte proliferation in these tissues may be an important but overlooked function of SXR.
Discussion
There is a growing body of evidence showing that nuclear receptors play important roles in regulating proliferation of lymphoid cells. Bensinger et al. (47) recently showed that loss of the nuclear receptor liver X receptor resulted in enhanced proliferation of T cells, linking sterol metabolism to the acquired immune response. Coste et al. (48) showed B cell lymphoma in aged steroid receptor coactivator-3 null mice. Mice lacking the retinoid-related orphan receptor ROR␥ exhibited lymphocyte accumulations in the spleen (49) and T cell lymphoma (50) , and animals lacking the nuclear receptors Nr4a3 and Nr4a1 develop acute myeloid leukemia (51) . These data show that nuclear hormone receptors play key roles in regulating lymphocyte proliferation.
The association between SXR loss of function and lymphoma provides an important and potentially causal link between xenobiotic chemicals and tumor formation. Our results suggest that compounds that inactivate SXR may lead to chronic inflammation and to lymphomas over time. Xenobiotic chemicals and pollutants have been associated with increased risk of nonHodgkin's lymphoma, particularly polychlorinated biphenyls (PCB) (52, 53) . We have previously shown that highly chlorinated PCB are antagonists of human SXR (54) . Notable among the PCB that antagonize SXR and those that have been associated with increased risk of non-Hodgkin's lymphoma is PCB153. Therefore, our results suggest a potential mechanistic link between xenobiotic chemicals that antagonize SXR and the development of lymphatic cancers.
Although data linking SXR to cancers are scant, analysis of microarray data from a variety of cancers deposited in Oncomine suggests a potential association between reduced SXR expression and lymphatic malignancies. It is not possible at this time to determine whether SXR down-regulation is causal in these cancers or instead represents the result of NF-B inhibiting SXR expression. Our ongoing studies aim to examine SXR polymorphisms, expression, and activity in human lymphomas. SXR expression in untreated tumors will be of particular interest, because chemotherapeutic agents may lead to an up-regulation of SXR expression, thereby masking down-regulation of SXR in the initial tumor. It will also be important to determine whether SXR agonists have clinical utility in treating lymphatic tumors, particularly those driven by aberrantly high NF-B activity.
Overall, our findings are consistent with a model in which down-regulation, repression, or loss of SXR function may play a key role in the development of B cell lymphoma. Thus, SXR unexpectedly functions as a tumor suppressor in B-1 cells. These data also suggest a role for SXR as an important modulator of immune function and environmental sensing beyond its role as a xenobiotic receptor. It is possible, albeit unproven, that SXR works cooperatively with the B-1 cell compartment to detect foreign threats. This work establishes a pivotal role for SXR in cell fate decisions at the crossroads of the innate and adaptive immune response, and secures a role for SXR in the regulation of the B-1 lymphocyte compartment and as a potential therapeutic target for diseases such as B cell malignancies.
Materials and Methods
Lymphocyte analysis and flow cytometry
Tissues were manually dissociated and strained to remove debris, and lysis buffer [0.15 M NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA (pH 7.3)] was used to remove red blood cells. Blood samples were mixed with 5 mM EDTA, and red blood cells were lysed. Cells were washed and resuspended in cold flow cytometry buffer (1% fetal bovine serum, 0.1% sodium azide in PBS). Antibodies were purchased from BD Bioscience (San Jose, CA) (CD5 allophycocyanin (APC), B220 fluorescein isothiocyanate (FITC), IgD APC, IgM phycoerythrin (PE), and IgM APC), BD PhosFlow (Alexa Fluor 488 Lck pY505 and PE Zap-70 Y319), eBioscience (San Diego, CA) (CD3 PE, CD3 phycoerythrin-cyanin 5.5 (PE-Cy5.5), CD8 APC, B220 PE-Cy5.5, IgD FITC, CD4 PE-Cy5.5, CD11b FITC, CD11c PE, CD21 FITC, CD25 PE, CD38 FITC, and Gr-1 PE), Biolegend (San Diego, CA) (Ig light chain ), and Invitrogen Zymed (Carlsbad, CA) (Ig light chain PE), and staining was performed according to the manufacturer's protocol. Biotinylated Ig light chain was detected with streptavidin-FITC (eBioscience, San Diego, CA). Cells were analyzed on FACSCalibur (Becton Dickinson, Mountain View, CA) and data were analyzed using FlowJo (Treestar, Ashland, OR). Each plot is representative of three or more animals.
Proliferation studies
Single-cell suspensions were prepared by manual dissociation, straining, and red blood cell lysis. Cells were grown at 5% CO 2 at 37 C in RPMI 1640 supplemented with 50 M 2-mercaptoethanol, 10% fetal calf serum, 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine, and 10 mM HEPES in round-bottom 96-well plates. CyQuant proliferation assay (Invitrogen) was performed as described (55) .
RNA isolation, cDNA preparation, and qRT-PCR
RNA was isolated using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. cDNA was synthesized using SuperScript III (Invitrogen). qRT-PCR was performed using specific primers (Supplemental Table 1 ) and the SYBR Green QPCR kit (Applied Biosystems, Foster City, CA) in a DNA Engine Opticon fluorescence detection system (Bio-Rad, Hercules, CA). Data were analyzed using the cycle threshold method (normalized to GAPDH). Peritoneal B-1a cells were purified using magnetic beads (Miltenyi Biotec, Auburn, CA) to deplete CD90.2 and enrich for CD5.
Western blotting
Tissues were homogenized in ice-cold RIPA buffer [137 mM NaCl, 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 0.5% Nonidet P-40, 10% glycerol, 2 mM EDTA (pH 8.0)] plus protease inhibitors (RPI Corp., Mt. Prospect, Illinois). Proteins were separated on 10% SDS-PAGE gels and were transferred to Immobilon membrane (Millipore, Billerica, MA) using the semi-dry method (Bio-Rad, Hercules, CA). Western blot analysis was performed as previously described (55) , and bands were detected using the ECL Plus Western blotting detection system (Amersham Bioscience, Piscataway, NJ).
Cloning and sequencing
V H DJ H -Cmu transcripts were amplified from cDNA with a universal Vh FR1 forward primer (5Ј-SARGTNMAGCTG-SAGSAGTC-3Ј) and a Cmu reverse primer (5Ј-CTTATCAGA-CAGGGGGCTCT-3Ј) using a Biolase DNA polymerase (Bioline, Tauton, MA). Cloning was performed using TOPO-TA cloning kit for sequencing (Invitrogen), and DNA was purified using a miniprep kit (Zyppy, Zymo Research, Irvine, CA). GeneWiz performed sequencing using an M13R primer, and sequences were aligned using multiple alignment program for amino acid or nucleotide sequences (MAFFT version 6).
Lymphocyte transplantation studies
B-1a cells were harvested from SXR Ϫ/Ϫ spleens or unchallenged peritoneal lavage of control mice. Cells were depleted for CD90.2 and enriched for CD5 using magnetic beads (Miltenyi Biotec). Both WT and SXR KO cells were determined to be approximately 92% pure as determined by flow cytometry (Supplemental Fig. 10) , and 2.5 ϫ 10 5 SXR Ϫ/Ϫ or WT cells were injected into the retroorbital venous sinus of 8-wk-old NOD/ SCID animals that had received 250 cGy total body irradiation. Recipient mice were divided into two arms of the experiment (2 and 6 wk). Mice were euthanized when they showed symptoms of chronic disease; 25% of KO-recipient mice were euthanized at 41 d, and 75% were euthanized at 45 d. Mice that received 250 cGy total body irradiation but received control cells (WT B-1a cells) were monitored for 12 wk after transplant, and none developed disease.
Animals and histological evaluation
Animals were identically raised and housed at the University of California, Irvine, and were maintained on a standard diet.
For histology, tissues were fixed in 4% buffered formalin, embedded in paraffin, and sectioned and stained with hematoxylin and eosin. Serum protein electrophoresis and rate nephelometry (IgM) were performed by University of California, Irvine, Pathology Services. Animal care and use was in accordance with applicable standards and approved by the Institutional Animal Care and Use Committees at the University of California, Irvine. SXR Ϫ/Ϫ mice were descendents of a gift from the Salk Institute; all other animals were purchased from Taconic Farms (Germantown, NY).
Statistics
Differences between groups were analyzed using Student's t test (parametric) or Mann-Whitney U test (nonparametric). A P value Ͻ0.05 was considered to be significant, and is indicated by a single asterisk, whereas P Ͻ 0.01 is indicated by two asterisks, and P Ͻ 0.001 is indicated by three asterisks. Graphs are presented as the mean Ϯ SEM. Analyses were performed with Prism 4 program (GraphPad Software, San Diego, CA).
